top of page
News / Notice
DewCell is shaping a better future through innovations in platelet technology.
Home > News / Notice
Dewcell demonstrates world’s first 50-liter bioreactor production of artificial platelets
Two 50-liter bioreactors to be installed at Anyang plant in H1 to support mass production Artificial platelets being produced in a 50-liter bioreactor (source : Dewcell) [by Kang, In Hyo] Dewcell, a South Korea–based company developing artificial platelet technologies, announced on January 30 that it has successfully produced artificial platelets using a 50-liter bioreactor for the first time globally. The company had established an artificial platelet manufacturing process e
18 hours ago
Korean biotech firm DewCell partners with Thermo Fisher on artificial platelet project
DewCell CTO Kim Chi-hwa and Thermo Fisher Scientific director Han Jun-sung at the partnership signing ceremony, June 30, 2025. Courtesy of DewCell SEOUL, July 1 (AJP) - DewCell, a South Korean biotechnology company specializing in stem cell-based therapies, announced Tuesday that it has launched a collaboration with Thermo Fisher Scientific of the United States to develop a customized culture medium for the large-scale production of artificial platelets. The partnership will
Jul 2, 2025
PL BioScience and DewCell to jointly develop artificial human platelets for scalable cell culture media
"This collaboration is an important step on the way to replacing conventional products of animal origin" Computer-generated image PL BioScience GmbH, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with Korean biotech company DewCell Biotherapeutics for the supply of artificial platelet raw material. Under the terms of the agreement, DewCell will
May 22, 2025
bottom of page